On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...